Compare TRNR & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRNR | SXTP |
|---|---|---|
| Founded | 2017 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0M | 2.9M |
| IPO Year | 2023 | 2023 |
| Metric | TRNR | SXTP |
|---|---|---|
| Price | $0.62 | $4.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $17.60 |
| AVG Volume (30 Days) | 2.6M | ★ 10.1M |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,774,000.00 | $1,364,945.00 |
| Revenue This Year | $245.67 | $146.28 |
| Revenue Next Year | $308.85 | $24.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 207.36 | 202.10 |
| 52 Week Low | $0.61 | $1.36 |
| 52 Week High | $39.60 | $24.00 |
| Indicator | TRNR | SXTP |
|---|---|---|
| Relative Strength Index (RSI) | 24.69 | 85.16 |
| Support Level | $0.64 | $1.86 |
| Resistance Level | $1.62 | $8.62 |
| Average True Range (ATR) | 0.15 | 0.48 |
| MACD | 0.00 | 0.48 |
| Stochastic Oscillator | 0.66 | 51.21 |
Interactive Strength Inc provides an integrated home fitness platform that allows its customers to participate in interactive wellness and strength-based training sessions. Its health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. The company generates revenue from sales of its connected fitness products, membership revenue, and personal training revenue.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.